Saniona announced that the board of directors has elected Jørgen Drejer, co-founder and current board member, as interim Chairman effective April 30, 2022, until the Annual General Meeting (AGM) to be held on May 25, 2022, when the Nominating Committee intends to propose that he becomes Chairman. Effective April 30, 2022, Saniona's executive management team will include Karin Sandager Nielsen as Chief Scientific Officer. Karin Sandager Nielsen is currently Senior Vice President In Vivo and Translational Pharmacology at Saniona.

Existing board members J. Donald deBethizy, Robert E. Hoffman and Edward C. Saltzman have informed the company that they are not available for re-election at the Annual General Meeting (AGM) to be held on May 25, 2022.